Brief Research Report
Published on 05 Oct 2022
Ligand-based discovery of a novel GATA2 inhibitor targeting acute myeloid leukemia cells
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1013229
- 4,574 views
- 4 citations
152 Publications
volumes
Volume 2 - 2022
Perspective
Published on 04 Oct 2022
How artificial intelligence enables modeling and simulation of biological networks to accelerate drug discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1019706
- 8,991 views
- 10 citations
Original Research
Published on 23 Sep 2022
Integrating diverse layers of omic data to identify novel drug targets in Listeria monocytogenes
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.969415
- 3,248 views
- 7 citations
Specialty Grand Challenge
Published on 23 Sep 2022
The grand challenge of discovering new cardiovascular drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1027401
- 9,655 views
- 14 citations
Clinical Trial
Published on 09 Sep 2022
Effect of itraconazole on the safety and pharmacokinetics of antitumor SHR6390
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.963045
- 3,329 views
- 1 citation
Editorial
Published on 08 Sep 2022
Editorial: Development of COVID-19 therapies: Lessons learnt and ongoing efforts
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1019705
- 1,102 views
- 1 citation
Original Research
Published on 31 Aug 2022
Bismuth subsalicylate as potential treatment for Covid-19 pneumonia: A case series report
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.962988
- 18,368 views
Brief Research Report
Published on 29 Aug 2022
Antifungal properties of (2S, 4R)-Ketoconazole sulfonamide analogs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1000827
- 2,171 views
- 2 citations
Review
Published on 26 Aug 2022
The challenges and opportunities for the development of COVID-19 therapeutics and preparing for the next pandemic
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.925825
- 8,720 views
- 1 citation
Opinion
Published on 24 Aug 2022
Current advances in our understanding of circular RNA (circRNA) in Alzheimer’s disease (AD); the potential utilization of synthetic circRNAs as a therapeutic strategy in the clinical management of AD
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.983030
- 2,133 views
- 9 citations
Mini Review
Published on 11 Aug 2022
Modeling heart failure with preserved ejection fraction in rodents: Where do we stand?
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.948407
- 4,999 views
- 1 citation
Brief Research Report
Published on 10 Aug 2022
Stemness inhibition by (+)-JQ1 in canine and human mammary cancer cells revealed by machine learning
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.953988
- 3,991 views
- 3 citations
Mini Review
Published on 18 Jul 2022
Nanobodies: COVID-19 and Future Perspectives
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.927164
- 10,960 views
- 15 citations
Clinical Trial
Published on 15 Jul 2022
Reszinate—A Phase 1/2 Randomized Clinical Trial of Zinc and Resveratrol Utilizing Home Patient-Obtained Nasal and Saliva Viral Sampling
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.910124
- 5,679 views
- 1 citation
Brief Research Report
Published on 08 Jul 2022
The Prospects of Monte Carlo Antibody Loop Modelling on a Fault-Tolerant Quantum Computer
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.908870
- 4,675 views
- 11 citations
Perspective
Published on 30 May 2022
Addressing Antibiotic Failure—Beyond Genetically Encoded Antimicrobial Resistance
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.892975
- 9,043 views
- 22 citations
Mini Review
Published on 26 May 2022
Overcoming Market Failures in Pandemic Drug Discovery Through Open Science: A Canadian Solution
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.898654
- 8,180 views
- 5 citations
Review
Published on 10 May 2022
Peptide-Based Strategies Against SARS-CoV-2 Attack: An Updated In Silico Perspective
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.899477
- 6,676 views
- 12 citations
Mini Review
Published on 10 May 2022
Furin and COVID-19: Structure, Function and Chemoinformatic Analysis of Representative Active Site Inhibitors
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.899239
- 8,426 views
- 21 citations
Review
Published on 02 May 2022
Advances in Modelling COVID-19 in Animals
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.899587
- 10,885 views
- 1 citation
Review
Published on 25 Apr 2022
Developing Small-Molecule Inhibitors of Protein-Protein Interactions Involved in Viral Entry as Potential Antivirals for COVID-19
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.898035
- 7,484 views
- 15 citations
Mini Review
Published on 13 Apr 2022
COVID-19 Therapies: Protease Inhibitions and Novel Degrader Strategies
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.892057
- 4,101 views
- 6 citations
Review
Published on 30 Mar 2022
The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.837587
- 8,585 views
- 10 citations
Review
Published on 22 Mar 2022
Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.858006
- 69,004 views
- 4 citations